In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Jason Shafrin, Senior Managing Director, Center for Health Economics and Policy, FTI Consulting.
Questions:
00:00: Introduction
01:15: You’ve worked across government, pharma, consulting, NGOs, and academia. What ties it all together, and what are you trying to solve now?
03:35: Was there a moment that drew you to health economics, or was it a gradual pull?
05:47: You’ve written on value frameworks and outcomes for reimbursement. If you could redesign HTA from scratch, what would you toss and what would you keep?
09:53: You’ve said incentives drive behavior, and competing incentives are a constant challenge. What’s the most misaligned incentive in healthcare today – and who does it hurt most?
15:19: With growing scrutiny of RWE and digital health, is oversight enabling or stifling innovation?
17:54: What’s one policy or regulation you believe is well-intentioned, but has led to poor health or economic outcomes?
22:31: On July 31, President Trump asked 17 pharma companies to match US drug prices to other developed nations. As a health economist, do you think this will work?
27:14: Rapid Fire Questions
Jason Shafrin
Senior Managing Director, Center for Health Economics and Policy, FTI Consulting
Jason Shafrin, PhD, is a Senior Managing Director at FTI Consulting's Center for Healthcare Economics and Policy. Dr Shafrin has over 20 years of health economics research experience serving as trusted advisor and expert to a wide variety of healthcare and life sciences companies, governments and non-governmental organizations (NGOs). Dr Shafrin is an Adjunct Professor at the University of Southern California, the former Director of Research at the Innovation and Value Initiative and the Founder and Editor of the Healthcare Economist blog. Dr Shafrin is an expert in applied economics with a specialty in health economics research. Over his career, he has developed novel methodological approaches, advanced quantitative analyses and innovative modeling to address some of the most difficult health economics problems and provide evidence-based solutions for clients across the healthcare industry. His work has assisted clients in addressing policy changes, navigating regulatory processes, evaluating pricing, value and outcomes and supporting innovation and transformative change. Dr Shafrin’s extensive experience includes projects on value assessment, alternative payment model design, discrete choice experiment survey, real-world data analysis, and digital medicine.
","author_name":"The Evidence Base"}